Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Reinisch, W; Dejaco, C; Feichtenschlager, T; Haas, T; Kaser, A; Miehsler, W; Novacek, G; Petritsch, W; Platzer, R; Tilg, H; Vogelsang, H; Knoflach, P; Arbeitsgruppe Chronisch-entzündliche Darmerkrankungen der ÖGGH.
Infliximab therapy for Crohn's disease - a practical guideline: actualised consensus of the working group for chronic inflammatory bowel diseases of the Austrian Society for Gastroenterology and Hepatology].
Z Gastroenterol. 2011; 49(4):534-542
Doi: 10.1055/s-0029-1245930
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Petritsch Wolfgang
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Infliximab is a monoclonal antibody against tumor necrosis factor alpha (TNF-α), which is approved for the treatment of chronic inflammatory bowel disease (IBD) such as Crohn's disease (CD), fistulating Crohn's disease (FCD), ulcerative colitis (UC), and paediatric ulcerative colitis (PUC) from 6 years onwards. Besides its therapeutic efficacy, this antibody therapy is characterised by its side effects profile, which has been addressed in a seperate consensus statement by the Working Group for chronic inflammatory bowel diseases within the Austrian Society for Gastroenterology and Hepatology. Infliximab is an effective treatment option for the above-mentioned indications; however, use of this agent requires special knowledge to assess the benefit-risk profile for each patient individually. © Georg Thieme Verlag KG Stuttgart · New York.
- Find related publications in this database (using NLM MeSH Indexing)
- Anti-Inflammatory Agents - therapeutic use
- Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use
- Crohn Disease - drug therapy
- Gastroenterology - standards
- Gastrointestinal Agents - therapeutic use
- Gastrointestinal Agents -
- Humans -
- Infliximab -
- Practice Guidelines as Topic -
- Find related publications in this database (Keywords)
- infliximab
- inflammatory bowel disease
- Crohn's disease
- fistulating Crohn's disease
- ulcerative colitis